Latest news with #LyellImmunopharmaInc
Yahoo
13-05-2025
- Business
- Yahoo
Lyell Immunopharma: Q1 Earnings Snapshot
SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Lyell Immunopharma Inc. (LYEL) on Tuesday reported a loss of $52.2 million in its first quarter. On a per-share basis, the South San Francisco, California-based company said it had a loss of 18 cents. The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 19 cents per share. The biotechnology firm posted revenue of $7,000 in the period. _____ This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on LYEL at Sign in to access your portfolio
San Francisco Chronicle
13-05-2025
- Business
- San Francisco Chronicle
Lyell Immunopharma: Q1 Earnings Snapshot
SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Lyell Immunopharma Inc. (LYEL) on Tuesday reported a loss of $52.2 million in its first quarter. On a per-share basis, the South San Francisco, California-based company said it had a loss of 18 cents. The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 19 cents per share. The biotechnology firm posted revenue of $7,000 in the period. _____
Washington Post
13-05-2025
- Business
- Washington Post
Lyell Immunopharma: Q1 Earnings Snapshot
SOUTH SAN FRANCISCO, Calif. — SOUTH SAN FRANCISCO, Calif. — Lyell Immunopharma Inc. (LYEL) on Tuesday reported a loss of $52.2 million in its first quarter. On a per-share basis, the South San Francisco, California-based company said it had a loss of 18 cents. The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 19 cents per share.
Yahoo
13-05-2025
- Business
- Yahoo
Lyell Immunopharma: Q1 Earnings Snapshot
SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Lyell Immunopharma Inc. (LYEL) on Tuesday reported a loss of $52.2 million in its first quarter. On a per-share basis, the South San Francisco, California-based company said it had a loss of 18 cents. The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 19 cents per share. The biotechnology firm posted revenue of $7,000 in the period. _____ This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on LYEL at Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
